Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iguratimod + Methotrexate in Rheumatoid Arthritis
NCT00965757Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jul 2009
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of iguratimod in rheumatoid arthritis (RA), sponsored by Eisai Co., Ltd.. Started Jul 2009; status: completed.
02
Drugs
iguratimod
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00965757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00965757.